Neurosterix
PrivateLast Round
Series A
Apr 3, 2024
Est. Valuation
$98M
Total Funding Raised
$65M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neurosterix is a biopharmaceutical company that develops allosteric modulator therapeutics for the treatment of neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurosterix Comparables
Compare Neurosterix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Addex Therapeutics | 81% | |
| Neumora | 80% | |
| Noema Pharma | 75% | |
Neurosterix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 3, 2024 |
Neurosterix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perceptive Advisors | Series A |
| Xontogeny | Series A |
| Acorn Bioventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 702% MoM.
- Apr 2, 2024
$65M round led by Perceptive Advisors and Xontogeny
Neurosterix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurosterix's valuation, stock price, and market status.